Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1985 | 0.1985 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0181 | 1 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.011 | 0.1439 | 0.1439 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0181 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.011 | 0.1439 | 1 |
Echinococcus multilocularis | neuroligin | 0.011 | 0.1439 | 0.1439 |
Onchocerca volvulus | 0.011 | 0.1439 | 0.5 | |
Echinococcus granulosus | acetylcholinesterase | 0.0649 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0351 | 0.0351 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.011 | 0.1439 | 0.1439 |
Loa Loa (eye worm) | carboxylesterase | 0.0649 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.011 | 0.1439 | 0.1439 |
Brugia malayi | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.011 | 0.1439 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.011 | 0.1439 | 0.1439 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0181 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1985 | 0.1985 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0181 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0653 | 0.0653 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.011 | 0.1439 | 0.1439 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0653 | 0.0653 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.011 | 0.1439 | 0.5 |
Onchocerca volvulus | 0.011 | 0.1439 | 0.5 | |
Loa Loa (eye worm) | carboxylesterase | 0.011 | 0.1439 | 0.1439 |
Echinococcus granulosus | acetylcholinesterase | 0.0649 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.011 | 0.1439 | 0.1439 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0181 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0181 | 0.0181 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1985 | 0.1985 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0653 | 0.0653 |
Onchocerca volvulus | 0.011 | 0.1439 | 0.5 | |
Echinococcus multilocularis | acetylcholinesterase | 0.0649 | 1 | 1 |
Onchocerca volvulus | 0.011 | 0.1439 | 0.5 | |
Loa Loa (eye worm) | carboxylesterase | 0.011 | 0.1439 | 0.1439 |
Echinococcus multilocularis | acetylcholinesterase | 0.0649 | 1 | 1 |
Echinococcus granulosus | neuroligin | 0.011 | 0.1439 | 0.1439 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0181 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Onchocerca volvulus | 0.011 | 0.1439 | 0.5 | |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.011 | 0.1439 | 0.1439 |
Echinococcus granulosus | carboxylesterase 5A | 0.0649 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.011 | 0.1439 | 0.1439 |
Schistosoma mansoni | acetylcholinesterase | 0.011 | 0.1439 | 0.1439 |
Brugia malayi | hypothetical protein | 0.002 | 0.001 | 0.001 |
Schistosoma mansoni | gliotactin | 0.011 | 0.1439 | 0.1439 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0351 | 0.0351 |
Loa Loa (eye worm) | hypothetical protein | 0.0649 | 1 | 1 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.011 | 0.1439 | 0.1439 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0181 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0181 | 1 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.011 | 0.1439 | 0.1439 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.011 | 0.1439 | 0.1439 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0653 | 0.0653 |
Loa Loa (eye worm) | hypothetical protein | 0.0649 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.011 | 0.1439 | 0.1439 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.011 | 0.1439 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.011 | 0.1439 | 0.1439 |
Brugia malayi | hypothetical protein | 0.003 | 0.0181 | 0.0181 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0649 | 1 | 1 |
Echinococcus granulosus | BC026374 protein S09 family | 0.011 | 0.1439 | 0.1439 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.011 | 0.1439 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0649 | 1 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0649 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0649 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.011 | 0.1439 | 0.1439 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0351 | 0.0351 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1439 | 0.1439 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.011 | 0.1439 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 6.7016 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.